Keywords: Schistosomiasis, Bilharzia, Research collaboration, Praziquintel. T Pharma, Merck KGaA, Astellas, Tropical and Public Health Institute
New public-private partnership to develop a treatment for schistosomiasis-infected pre-school children
Article | 02 July 2012
A newly established international public-private partnership (PPP) between the Dutch non-profit organization TI Pharma, Germany’s Merck KGaA (MRK: ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
